Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5]

Details Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5] Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5]

1989-01-26

1990-02-27

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

544 99, C07D41304, A61K 31435

Patent

active

049046551

ABSTRACT:
Novel compounds selected from the group consisting of all possible racemic or optically active forms of compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 5 carbon atoms, -OH, -CF.sub.3 and -NO.sub.2 and ##STR2## is selected from the group consisting of ##STR3## and their non-toxic, pharmaceutically acceptable acid addition salts having a very good analgesic activity as well as antidepressive, neuronal protective, anti-anoxic, anti-ischemic and no-otropic activities.

REFERENCES:
patent: 4493836 (1985-01-01), Nedelec et al.

Affiliated with

Also associated with

Rating

Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5] does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5], we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel indolo [3,2,1-de] [1,4] oxazino [2,3,4-ij] [1,5] will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174329